BRPI0715087A2 - Método de tratamento de disfunção termoregulatória com paroxetina - Google Patents
Método de tratamento de disfunção termoregulatória com paroxetinaInfo
- Publication number
- BRPI0715087A2 BRPI0715087A2 BRPI0715087-3A2A BRPI0715087A BRPI0715087A2 BR PI0715087 A2 BRPI0715087 A2 BR PI0715087A2 BR PI0715087 A BRPI0715087 A BR PI0715087A BR PI0715087 A2 BRPI0715087 A2 BR PI0715087A2
- Authority
- BR
- Brazil
- Prior art keywords
- thermoegulatory
- dyfunction
- paroxetine
- treatment
- function
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/499,586 US20080033050A1 (en) | 2006-08-04 | 2006-08-04 | Method of treating thermoregulatory disfunction with paroxetine |
PCT/US2007/017062 WO2008019010A2 (en) | 2006-08-04 | 2007-07-31 | Method of treating thermoregulatory disfunction with paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0715087A2 true BRPI0715087A2 (pt) | 2015-02-10 |
Family
ID=39030027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0715087-3A2A BRPI0715087A2 (pt) | 2006-08-04 | 2007-07-31 | Método de tratamento de disfunção termoregulatória com paroxetina |
Country Status (27)
Country | Link |
---|---|
US (7) | US20080033050A1 (pt) |
EP (2) | EP2068881B1 (pt) |
JP (2) | JP5846717B2 (pt) |
KR (3) | KR20140098865A (pt) |
CN (1) | CN101505759A (pt) |
AU (1) | AU2007282065B2 (pt) |
BR (1) | BRPI0715087A2 (pt) |
CA (1) | CA2659577C (pt) |
CY (2) | CY1120867T1 (pt) |
DK (2) | DK2719385T3 (pt) |
ES (2) | ES2698207T3 (pt) |
HR (2) | HRP20181893T1 (pt) |
HU (2) | HUE040481T2 (pt) |
IL (1) | IL196844A (pt) |
LT (2) | LT2068881T (pt) |
ME (1) | ME00592A (pt) |
MX (1) | MX2009001275A (pt) |
NO (1) | NO343176B1 (pt) |
NZ (1) | NZ574735A (pt) |
PL (2) | PL2068881T3 (pt) |
PT (2) | PT2719385T (pt) |
RS (2) | RS58046B1 (pt) |
RU (1) | RU2478379C2 (pt) |
SG (1) | SG176452A1 (pt) |
SI (2) | SI2719385T1 (pt) |
UA (1) | UA96770C2 (pt) |
WO (1) | WO2008019010A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
US9211290B2 (en) * | 2012-12-31 | 2015-12-15 | Noven Therapeutics, Llc | Solid dispersions of amorphous paroxetine mesylate |
JP6038416B1 (ja) * | 2015-04-07 | 2016-12-07 | 株式会社明治 | 火照り抑制剤 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
GB8520154D0 (en) * | 1985-08-10 | 1985-09-18 | Beecham Group Plc | Chemical process |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
GB8714707D0 (en) * | 1987-06-23 | 1987-07-29 | Beecham Group Plc | Chemical process |
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
US5470846A (en) * | 1994-01-14 | 1995-11-28 | Sandyk; Reuven | Treatment of neurological and mental disorders |
JPH0837567A (ja) | 1994-07-26 | 1996-02-06 | Olympus Optical Co Ltd | 情報記録媒体及び情報再生装置 |
US5856493A (en) * | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
JP3882224B2 (ja) * | 1996-05-31 | 2007-02-14 | 旭硝子株式会社 | パロキセチンの製造方法 |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
CA2193939C (en) * | 1996-12-24 | 2002-02-12 | K.S. Keshava Murthy | Useful form of anhydrous paroxetine hydrochloride |
GB9700690D0 (en) * | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
GB9710004D0 (en) * | 1997-05-17 | 1997-07-09 | Knoll Ag | Chemical process |
AU7708998A (en) * | 1997-05-29 | 1998-12-30 | Smithkline Beecham Corporation | Novel process |
US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
KR100543614B1 (ko) * | 1997-06-10 | 2006-01-20 | 신톤 비.브이. | 4-페닐피페리딘 화합물 |
US5955475A (en) * | 1997-06-30 | 1999-09-21 | Endo Pharmaceuticals Inc. | Process for manufacturing paroxetine solid dispersions |
SE9900190D0 (sv) * | 1999-01-22 | 1999-01-22 | Astra Ab | New compounds |
SE9702799D0 (sv) * | 1997-07-25 | 1997-07-25 | Astra Ab | New compounds |
US6133277A (en) * | 1997-12-05 | 2000-10-17 | Janssen Pharmaceutica N.V. | (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
EA200000890A1 (ru) | 1998-03-02 | 2001-02-26 | Эли Лилли Энд Компани | Гидрохлорид флуоксетина для уменьшения "приливов" (приступообразных ощущений жара (при климактерическом синдроме)) |
JP2002506865A (ja) * | 1998-03-16 | 2002-03-05 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | パロキセチンの結晶形 |
US6699882B2 (en) * | 1998-03-24 | 2004-03-02 | Smithkline Beecham P.L.C. | Paroxetine compositions |
US20030028027A1 (en) * | 1998-04-09 | 2003-02-06 | Smithkline Beecham Plc | Paroxetine maleate |
JP3796351B2 (ja) * | 1998-04-13 | 2006-07-12 | 住友化学株式会社 | パロキセチン塩酸塩無水和物の乾燥方法 |
US6168805B1 (en) | 1998-05-07 | 2001-01-02 | Endo Pharmaceuticals, Inc. | Aqueous process for manufacturing paroxetine solid dispersions |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
ES2138937B1 (es) * | 1998-07-07 | 2000-10-01 | Medichem Sa | Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen. |
ES2159260B1 (es) * | 1999-06-22 | 2002-05-01 | Smithkline Beechan Plc | Nueva composicion de metanosulfonato de paroxetina |
US6369051B1 (en) * | 2000-07-06 | 2002-04-09 | American Home Products Corporation | Combinations of SSRI and estrogenic agents |
US6660298B1 (en) * | 2000-07-27 | 2003-12-09 | Pentech Pharmaceuticals, Inc. | Paroxetine tablets and capsules |
HUP0303827A2 (hu) | 2000-08-28 | 2004-04-28 | Synthon B.V. | Paroxetinkészítmények és eljárások ezek előállítására |
US6498184B2 (en) * | 2000-12-05 | 2002-12-24 | Akzo Nobel N.V. | Serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
US6881845B2 (en) * | 2001-01-04 | 2005-04-19 | Ferrer Internacional, S.A. | Process for preparing (±)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
DE20100529U1 (de) | 2001-01-11 | 2001-05-10 | Synthon Bv | Pharmazeutische Tablette umfassend Paroxetinmesylat |
NL1017421C2 (nl) * | 2001-02-21 | 2002-01-15 | Synthon Bv | Werkwijze voor het vervaardigen van paroxetine. |
EP1266659A1 (en) | 2001-06-11 | 2002-12-18 | Pantarhei Bioscience B.V. | Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes |
US6956121B2 (en) * | 2002-03-01 | 2005-10-18 | Teva Pharmaceutical Industries Ltd. | Preparation of paroxetine involving novel intermediates |
BR0313411A (pt) * | 2002-08-14 | 2005-06-28 | Pharmacia & Upjohn Co Llc | Uso de reboxetina para o tratamento de ondas de calor |
US20040152710A1 (en) | 2002-10-15 | 2004-08-05 | Deecher Darlene Coleman | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
ITMI20022344A1 (it) * | 2002-11-05 | 2004-05-06 | Biofarm Srl | Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi. |
TWI267838B (en) * | 2003-01-03 | 2006-12-01 | Lite On It Corp | Method to detect the type of optical disk |
US20050130987A1 (en) | 2003-10-14 | 2005-06-16 | Wyeth | Methods of treating vasomotor symptoms |
BRPI0512182A (pt) * | 2004-07-22 | 2008-02-19 | Wyeth Corp | método para o tratamento de condições e desordens do sistema nervoso |
CA2574310A1 (en) * | 2004-07-22 | 2006-02-02 | Wyeth | Method for treating nervous system disorders and conditions |
US20060100263A1 (en) * | 2004-11-05 | 2006-05-11 | Anthony Basile | Antipyretic compositions and methods |
KR100764679B1 (ko) | 2005-07-22 | 2007-10-09 | 익수제약 주식회사 | 파록세틴을 함유하는 경피투여용 패취제 |
CN101325944B (zh) * | 2005-10-11 | 2013-01-16 | 耶路撒冷希伯来大学伊萨姆研究开发公司 | 用于鼻部给药的组合物 |
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
-
2006
- 2006-08-04 US US11/499,586 patent/US20080033050A1/en not_active Abandoned
-
2007
- 2007-07-31 JP JP2009522831A patent/JP5846717B2/ja not_active Expired - Fee Related
- 2007-07-31 CA CA2659577A patent/CA2659577C/en active Active
- 2007-07-31 HU HUE07810919A patent/HUE040481T2/hu unknown
- 2007-07-31 RS RS20181386A patent/RS58046B1/sr unknown
- 2007-07-31 DK DK13190594.5T patent/DK2719385T3/en active
- 2007-07-31 PL PL07810919T patent/PL2068881T3/pl unknown
- 2007-07-31 DK DK07810919.6T patent/DK2068881T3/en active
- 2007-07-31 ME MEP-37/09A patent/ME00592A/xx unknown
- 2007-07-31 SG SG2011081056A patent/SG176452A1/en unknown
- 2007-07-31 LT LTEP07810919.6T patent/LT2068881T/lt unknown
- 2007-07-31 SI SI200732079T patent/SI2719385T1/sl unknown
- 2007-07-31 CN CNA2007800289306A patent/CN101505759A/zh active Pending
- 2007-07-31 KR KR1020147020772A patent/KR20140098865A/ko not_active Application Discontinuation
- 2007-07-31 PL PL13190594T patent/PL2719385T3/pl unknown
- 2007-07-31 BR BRPI0715087-3A2A patent/BRPI0715087A2/pt not_active Application Discontinuation
- 2007-07-31 KR KR1020157032729A patent/KR20150132888A/ko not_active Application Discontinuation
- 2007-07-31 EP EP07810919.6A patent/EP2068881B1/en active Active
- 2007-07-31 SI SI200732071T patent/SI2068881T1/sl unknown
- 2007-07-31 AU AU2007282065A patent/AU2007282065B2/en not_active Ceased
- 2007-07-31 EP EP13190594.5A patent/EP2719385B1/en active Active
- 2007-07-31 HU HUE13190594A patent/HUE040099T2/hu unknown
- 2007-07-31 RS RS20181413A patent/RS57980B1/sr unknown
- 2007-07-31 ES ES07810919T patent/ES2698207T3/es active Active
- 2007-07-31 LT LTEP13190594.5T patent/LT2719385T/lt unknown
- 2007-07-31 KR KR1020097004195A patent/KR20090040453A/ko active Application Filing
- 2007-07-31 WO PCT/US2007/017062 patent/WO2008019010A2/en active Application Filing
- 2007-07-31 PT PT13190594T patent/PT2719385T/pt unknown
- 2007-07-31 NZ NZ574735A patent/NZ574735A/en not_active IP Right Cessation
- 2007-07-31 ES ES13190594T patent/ES2699298T3/es active Active
- 2007-07-31 UA UAA200901871A patent/UA96770C2/uk unknown
- 2007-07-31 RU RU2009107739/15A patent/RU2478379C2/ru not_active IP Right Cessation
- 2007-07-31 PT PT07810919T patent/PT2068881T/pt unknown
- 2007-07-31 MX MX2009001275A patent/MX2009001275A/es unknown
-
2008
- 2008-12-01 US US12/292,960 patent/US8658663B2/en active Active
-
2009
- 2009-02-02 IL IL196844A patent/IL196844A/en active IP Right Grant
- 2009-02-10 NO NO20090639A patent/NO343176B1/no not_active IP Right Cessation
-
2014
- 2014-01-17 US US14/157,992 patent/US8946251B2/en active Active
- 2014-02-06 JP JP2014021171A patent/JP5895009B2/ja not_active Expired - Fee Related
- 2014-05-13 US US14/276,494 patent/US8859576B2/en active Active
- 2014-12-19 US US14/577,227 patent/US9393237B2/en active Active
-
2016
- 2016-07-15 US US15/211,074 patent/US20170165251A1/en not_active Abandoned
-
2017
- 2017-10-17 US US15/785,769 patent/US20200268733A9/en not_active Abandoned
-
2018
- 2018-11-14 HR HRP20181893TT patent/HRP20181893T1/hr unknown
- 2018-11-19 CY CY181101219T patent/CY1120867T1/el unknown
- 2018-11-19 HR HRP20181925TT patent/HRP20181925T1/hr unknown
- 2018-11-23 CY CY181101241T patent/CY1120902T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018004I1 (el) | Συνδυαστικη θεραπεια υποκατεστημενης oξαζολιδινονης | |
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
BRPI0718313A2 (pt) | Conjunto de cateter | |
BRPI0910854A2 (pt) | métodos de tratamento | |
DK2371948T5 (da) | Lipasevarianter | |
FR2908035B1 (fr) | Implant interepineux | |
DK2059194T3 (da) | Håndledsimplantater | |
BRPI0716466A2 (pt) | Tratamento da calda de açúcar | |
CR10562A (es) | Nuevos derivados de piridazina | |
BRPI0720547A2 (pt) | Inibidores de metaloprotease derivada de heterocíclico | |
BRPI0716528A2 (pt) | mÉtodo de estabilizaÇço | |
DK2246477T3 (da) | Spunspæl med dobbelt t-form | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
BRPI0718145A2 (pt) | Método de micronização | |
BRPI0715728A8 (pt) | tratamento de distúrbios cartilaginosos | |
DE602007012260D1 (de) | Nitratester von piperidinen | |
DE602007013310D1 (de) | Hochfrequenzbehandlungsinstrument | |
FR2896995B1 (fr) | Raquette de paddleball | |
BRPI0715087A2 (pt) | Método de tratamento de disfunção termoregulatória com paroxetina | |
BRPI0718420A2 (pt) | Método de restabelecimento do efeito da incretina | |
MA29423B1 (fr) | Methode de grelonage | |
BRPI0716580A2 (pt) | Tratamento de distúrbios fibrosantes | |
FI20070037A0 (fi) | Menetelmä jätteen käsittelemiseksi | |
ITBA20060030A1 (it) | Stimolatore sessuale | |
UA14840S (uk) | Ванна гідромасажна |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: SEBELA INTERNATIONAL LIMITED (BM) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B25A | Requested transfer of rights approved |
Owner name: SEBELA INTERNATIONAL BERMUDA LIMITED (BM) |
|
B25A | Requested transfer of rights approved |
Owner name: SEBELA IRELAND LIMITED (IE) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |